These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30100197)

  • 21. ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.
    Härmark L; van Hunsel F; Grundmark B
    Drug Saf; 2015 Apr; 38(4):337-47. PubMed ID: 25627832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical device regulation: an introduction for the practicing physician.
    Maisel WH
    Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on the Efficacy of Fulfillment of Medical Device Adverse Event Monitoring Entities and Safeguard Mechanism].
    Ren W; Mao Y; Luo W; Ding J; Wang W; Zhu Q
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Jan; 42(1):58-61. PubMed ID: 29862750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database.
    Lawal OD; Mohanty M; Elder H; Skeer M; Erpelding N; Lanier R; Katz N
    Expert Opin Drug Saf; 2018 Apr; 17(4):347-357. PubMed ID: 29463158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Act to keep patients safe: device-related adverse event reporting.
    Schoem SR; Shah UK
    Otolaryngol Head Neck Surg; 2010 May; 142(5):651-3. PubMed ID: 20416450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enlightenment on Carrying out Reporting Responsibility of Manufactures in China from Reviewing Medical Device Reporting Practice in US].
    Zhao Y; Dong F; Zhao Y; Zheng L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Dec; 44(6):545-548. PubMed ID: 33314866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines.
    Pane J; Coloma PM; Verhamme KM; Sturkenboom MC; Rebollo I
    Drug Saf; 2017 Jan; 40(1):37-47. PubMed ID: 27928726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study.
    Worakunphanich W; Suwankesawong W; Youngkong S; Thavorncharoensap M; Anderson C; Toh LS
    Int J Clin Pharm; 2023 Apr; 45(2):491-501. PubMed ID: 36745312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
    McManus L; Fisher JA
    AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis on evaluation of medical device adverse events monitoring and some factors influencing MDAE's reporting by medical personnels].
    Liu AP; Zhang LM; Yan W; Zhang JH; Zhu YP
    Zhongguo Yi Liao Qi Xie Za Zhi; 2008 Jan; 32(1):47-9. PubMed ID: 18438052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse events with medical devices in anesthesia and intensive care unit patients recorded in the French safety database in 2005-2006.
    Beydon L; Ledenmat PY; Soltner C; Lebreton F; Hardin V; Benhamou D; Clergue F; Laguenie G
    Anesthesiology; 2010 Feb; 112(2):364-72. PubMed ID: 20098139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low awareness of adverse drug reaction reporting systems: a consumer survey.
    Robertson J; Newby DA
    Med J Aust; 2013 Nov; 199(10):684-6. PubMed ID: 24237099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statistics and Analysis of 136 Cases of Adverse Events of International Medical Devices].
    Zhao F; Gao M; Liu P; Wang Y; Zhang H; Zhang Y; Zhan Q; Wang S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):166-171. PubMed ID: 32400993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarketing safety of biologics and biological devices.
    Woo EJ
    Spine J; 2014 Mar; 14(3):560-5. PubMed ID: 24342704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious adverse event reporting in a medical device information system.
    Pecoraro F; Luzi D
    Stud Health Technol Inform; 2011; 169():834-8. PubMed ID: 21893864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary Reporting Program for Manufacturers. Notification; order granting alternative.
    Food and Drug Administration, HHS
    Fed Regist; 2018 Aug; 83(160):40973-85. PubMed ID: 30192471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partnering with consumers in the public reporting of quality of care: review of the Victorian quality of care reports.
    Zaga C; Leggat S; Hill S
    Aust Health Rev; 2018 Sep; 42(5):550-556. PubMed ID: 29566358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.